Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: IgGenix

IgGenix Doses Final Participant in Phase 1 Study of Novel Peanut...

A new era in food allergy treatment has begun

IgGenix to Present Alpha-gal Syndrome Monoclonal Antibody Discovery at 2025 AAAAI...

New Phase 1 Study in Peanut Allergy Recruiting Now in Australia

First Human Trials of IgGenix Peanut Allergy Treatment to Begin in...

IgGenix Demonstrates the Potential of Targeted Therapeutic for Peanut Allergy Ahead...

IgGenix Secures $40M Funding to Advance Antibody Therapy to Treat Food...

IgGenix Shows Potential of Platform to Advance Understanding of Tree Nut...

Company Developing Therapy to Prevent “Allergic Cascade” Emerges from Stealth Mode

Follow Us

Your School On Our Map

Put Your School on the Map